Projects per year
Personal profile
Research interests
Miller Lab Consortium. To date, our team has treated more than 400 patients with natural killer cell infusions and over a hundred patients with therapies that activate their own natural killer cells. We've retrospectively analyzed more than 5000 patients and enrolled more than 500 patients in prospective trials.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 12 Active
-
A PHASE 1, OPEN-LABEL, MULTICENTER STUDY OF JANX007 IN SUBJECTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Zorko, N. A. (PI)
1/3/25 → 1/2/36
Project: Research project
-
Evaluation of Vgamma9Vdelta2-T cells in the peripheral blood of patients with metastatic castration-resistant prostate cancer
Zorko, N. A. (PI)
7/24/24 → 7/23/35
Project: Research project
-
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer
Phung, S. K., Zorko, N. A., Soignier, Y., Waller, R. L., Shackelford, M., Walker, J. T., Nelson, T. D., Selleck, C., Bendzick, L. E., Kotz, L. E., Kile, Q. M., Bozicevich, A. J., Miller, S. E., Khaw, M., Shetty, M., Hinderlie, P., Ehrhardt, M., Li, Y., Luo, X. & Dehm, S. M. & 4 others, , Feb 1 2025, In: Cancer Immunology Research. 13, 2, p. 258-272 15 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting
Lozada, J. R., Elliott, A., Evans, M. G., Wacker, J., Storey, K. M., Egusa, E. A., Zorko, N. A., Kumar, A., Crymes, A., Heath, E. I., Carneiro, B. A., Soares, H. P., Cichocki, F. M., Miller, J. S., Lou, E., Beltran, H., Antonarakis, E. S., Ryan, C. & Hwang, J., Feb 1 2025, In: Cancer Research Communications. 5, 2, p. 318-326 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes
Zorko, N. A., Makovec, A., Elliott, A., Kellen, S., Lozada, J. R., Arafa, A. T., Felices, M., Shackelford, M., Barata, P., Zakharia, Y., Narayan, V., Stein, M. N., Zarrabi, K. K., Patniak, A., Bilen, M. A., Radovich, M., Sledge, G., El-Deiry, W. S., Heath, E. I. & Hoon, D. S. B. & 4 others, , Mar 2025, In: Prostate Cancer and Prostatic Diseases. 28, 1, p. 129-137 9 p., 34.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey-Holden Prostate Cancer Academy Meeting
Miyahira, A. K., Kamran, S. C., Jamaspishvili, T., Marshall, C. H., Maxwell, K. N., Parolia, A., Zorko, N. A., Pienta, K. J. & Soule, H. R., Aug 2024, In: Prostate. 84, 11, p. 993-1015 23 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer
Bergom, H. E., Sena, L. A., Day, A., Miller, B., Miller, C. D., Lozada, J. R., Zorko, N., Wang, J., Shenderov, E., Lobo, F. P., Caramella-Pereira, F., Marchionni, L., Drake, C. G., Lotan, T., De Marzo, A. M., Hwang, J. & Antonarakis, E. S., Dec 2024, In: npj Genomic Medicine. 9, 1, 7.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations